To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of testing newborn babies for spinal muscular atrophy.
Answered on
25 November 2024
Work is already underway to assess the potential merits of testing newborn babies for spinal muscular atrophy (SMA).
This is following the UK National Screening Committee’s two-fold recommendation in 2023, to simultaneously develop a new cost-effectiveness screening modelling study for the United Kingdom’s screening context, and to start scoping work for an in-service evaluation of newborn screening for SMA in real world National Health Services in the UK.
Answered by
Department of Health and Social Care
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.